Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qinjiao Dihuang Tongbi Tang is a Traditional Chinese Medicine (TCM) herbal decoction primarily used for the treatment of "Bi syndrome," which corresponds to inflammatory joint diseases such as rheumatoid arthritis and osteoarthritis, particularly those characterized by Yin deficiency and internal heat. The formula typically features *Gentiana macrophylla* (Qinjiao) and *Rehmannia glutinosa* (Dihuang) as its principal components. It functions by dispelling wind-dampness, clearing heat, and nourishing Yin and blood to alleviate joint pain, swelling, and stiffness. While primarily used in traditional clinical practice, modern pharmacological studies on its constituent herbs suggest anti-inflammatory, analgesic, and immunomodulatory effects, often mediated through the inhibition of pro-inflammatory cytokines.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on qinjiao dihuang tongbi tang.